S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Immunoprecise Antibodies Stock Price, News & Analysis (CVE:IPA)

C$0.50
+0.04 (+8.79 %)
(As of 10/14/2019 04:00 PM ET)
Today's Range
C$0.46
Now: C$0.50
C$0.50
50-Day Range
C$0.47
MA: C$0.55
C$0.65
52-Week Range
C$0.45
Now: C$0.50
C$0.94
Volume101,500 shs
Average Volume73,427 shs
Market CapitalizationC$33.65 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-8060626

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$10.77 million
Cash FlowC$0.08 per share
Book ValueC$0.23 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$33.65 million
Next Earnings Date11/27/2019 (Estimated)
OptionableNot Optionable

Receive IPA News and Ratings via Email

Sign-up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter.


Immunoprecise Antibodies (CVE:IPA) Frequently Asked Questions

What is Immunoprecise Antibodies' stock symbol?

Immunoprecise Antibodies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IPA."

How were Immunoprecise Antibodies' earnings last quarter?

Immunoprecise Antibodies Ltd (CVE:IPA) issued its quarterly earnings data on Wednesday, August, 28th. The company reported ($0.06) EPS for the quarter. The business had revenue of $2.64 million for the quarter. View Immunoprecise Antibodies' Earnings History.

When is Immunoprecise Antibodies' next earnings date?

Immunoprecise Antibodies is scheduled to release their next quarterly earnings announcement on Wednesday, November 27th 2019. View Earnings Estimates for Immunoprecise Antibodies.

Has Immunoprecise Antibodies been receiving favorable news coverage?

Press coverage about IPA stock has been trending negative this week, according to InfoTrie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Immunoprecise Antibodies earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Immunoprecise Antibodies.

Who are some of Immunoprecise Antibodies' key competitors?

What other stocks do shareholders of Immunoprecise Antibodies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunoprecise Antibodies investors own include Northwest Pipe (NWPX), Adaptimmune Therapeutics (ADAP), Acadia Healthcare (ACHC), WPP (WPP), South32 (S32), Faron Pharmaceuticals Oy (FARN), Infineon Technologies (IFXA), Daimler (DAI), Tres Or Resources (TRS) and Prism Medical (PM).

Who are Immunoprecise Antibodies' key executives?

Immunoprecise Antibodies' management team includes the folowing people:
  • Dr. James S. Kuo M.B.A., M.D., Chairman (Age 54)
  • Dr. Jennifer Bath, Pres, CEO & Director
  • Mr. Robert Beecroft, Founder & Director
  • Mr. Charles Wheelock, Global Chief Technology Officer
  • Ms. Lisa Helbling, Chief Financial Officer

How do I buy shares of Immunoprecise Antibodies?

Shares of IPA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Immunoprecise Antibodies' stock price today?

One share of IPA stock can currently be purchased for approximately C$0.50.

How big of a company is Immunoprecise Antibodies?

Immunoprecise Antibodies has a market capitalization of C$33.65 million and generates C$10.77 million in revenue each year. View Additional Information About Immunoprecise Antibodies.

What is Immunoprecise Antibodies' official website?

The official website for Immunoprecise Antibodies is http://immunoprecise.com/.

How can I contact Immunoprecise Antibodies?

Immunoprecise Antibodies' mailing address is 880-580 Hornby St, VANCOUVER, BC V6C 3B6, Canada. The company can be reached via phone at +1-604-8060626.


MarketBeat Community Rating for Immunoprecise Antibodies (CVE IPA)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  93
MarketBeat's community ratings are surveys of what our community members think about Immunoprecise Antibodies and other stocks. Vote "Outperform" if you believe IPA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel